These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30963565)

  • 1. Weaning from antiseizure drugs after new onset status epilepticus.
    Chakraborty T; Hocker S
    Epilepsia; 2019 May; 60(5):979-985. PubMed ID: 30963565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory status epilepticus: a developing country perspective.
    Sinha S; Prashantha DK; Thennarasu K; Umamaheshwara Rao GS; Satishchandra P
    J Neurol Sci; 2010 Mar; 290(1-2):60-5. PubMed ID: 19954801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
    Löscher W
    Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
    Hubert K; Knake S; Bauer S; Voss M; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2020 Aug; 109():107139. PubMed ID: 32417381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine use in the treatment of refractory status epilepticus.
    Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How often do doctors discuss drug withdrawal with their seizure-free patients with epilepsy?
    Henning O; Medalen TEM; Nakken KO; Lossius MI
    Epilepsy Behav; 2020 Jul; 108():107095. PubMed ID: 32320921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brexanolone as adjunctive therapy in super-refractory status epilepticus.
    Rosenthal ES; Claassen J; Wainwright MS; Husain AM; Vaitkevicius H; Raines S; Hoffmann E; Colquhoun H; Doherty JJ; Kanes SJ
    Ann Neurol; 2017 Sep; 82(3):342-352. PubMed ID: 28779545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
    Brigo F; Nardone R; Tezzon F; Trinka E
    Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
    Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
    Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcome in refractory status epilepticus.
    Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
    JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus.
    Creed JA; Son J; Farjat AE; Swisher CB
    Seizure; 2018 Jan; 54():45-50. PubMed ID: 29248799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.